Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR1 | Q9Y271 | 10/20 | 0.48 |
| ▸ | GRM2 | Q14416 | 8/20 | 0.48 |
| ▸ | MAOB | P27338 | 3/20 | 0.45 |
| ▸ | MAOA | P21397 | 2/20 | 0.45 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CTSD | P07339 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4937170 | 0.95 | CYSLTR1 (0.52) | CYSLTR1GRM2CYSLTR2FFAR1MAPT | |
| SCHEMBL5318352 | 0.93 | CYSLTR1 (0.44) | CYSLTR1GRM2MAOBMAOACYSLTR2 | |
| SCHEMBL4945030 | 0.86 | CYSLTR1 (0.60) | CYSLTR1GRM2MAOBMAOACYSLTR2 | |
| SCHEMBL3166919 | 0.80 | CYSLTR1 (0.62) | CYSLTR1GRM2CYSLTR2MAPTCYP2C9 | |
| SCHEMBL10730502 | 0.79 | CYSLTR1 (0.58) | CYSLTR1GRM2CYSLTR2MAPTCYP2C9 | |
| SCHEMBL10751332 | 0.79 | CYSLTR1 (0.58) | CYSLTR1GRM2CYSLTR2MAPTCYP2C9 | |
| SCHEMBL3172561 | 0.79 | CYSLTR1 (0.50) | CYSLTR1GRM2CYSLTR2MAPTCYP2C9 | |
| SCHEMBL3168116 | 0.78 | CYSLTR1 (0.49) | CYSLTR1GRM2CYSLTR2MAPTCYP2C9 | |
| SCHEMBL3174134 | 0.77 | CYSLTR1 (0.51) | CYSLTR1GRM2CYSLTR2MAPTCYP2C9 | |
| SCHEMBL2895915 | 0.76 | CYSLTR1 (0.47) | CYSLTR1GRM2CYSLTR2MAPTCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1773774-A2 | HETEROCYCLIC ACETOPHENONE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS | Merck & Co., Inc. (US) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006014918-A2 | HETEROCYCLIC ACETOPHENONE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS | MERCK & CO., INC. (US) | 2006-02-09 | — | — | WO | disclosed |